• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prandial and diurnal effects on the absorption of orally administered enteric coated 5-aminosalicylic acid (5-ASA).进餐和昼夜节律对口服肠溶5-氨基水杨酸(5-ASA)吸收的影响。
Br J Clin Pharmacol. 1992 Feb;33(2):179-82. doi: 10.1111/j.1365-2125.1992.tb04021.x.
2
Bioavailability of single and multiple doses of enteric-coated mesalamine and sulphasalazine.
J Int Med Res. 1990 Nov-Dec;18(6):441-53. doi: 10.1177/030006059001800601.
3
Pharmacokinetics of a 5-aminosalicylic acid enteric-coated tablet and suppository dosage form.5-氨基水杨酸肠溶片和栓剂剂型的药代动力学
Aliment Pharmacol Ther. 1989 Aug;3(4):333-42. doi: 10.1111/j.1365-2036.1989.tb00220.x.
4
Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission.溃疡性结肠炎缓解期患者从奥沙拉嗪和Eudragit L包衣美沙拉嗪中全身吸收5-氨基水杨酸的情况。
Z Gastroenterol. 1996 Apr;34(4):225-9.
5
Bioavailability of single and multiple doses of a new oral formulation of 5-ASA in patients with inflammatory bowel disease and healthy volunteers.炎症性肠病患者和健康志愿者单次及多次服用新型5-氨基水杨酸口服制剂的生物利用度。
Aliment Pharmacol Ther. 1994 Oct;8(5):535-40. doi: 10.1111/j.1365-2036.1994.tb00327.x.
6
Effect of food coadministration on 5-aminosalicylic acid oral suspension bioavailability.食物共同给药对5-氨基水杨酸口服混悬液生物利用度的影响。
Clin Pharmacol Ther. 1990 Jul;48(1):26-33. doi: 10.1038/clpt.1990.113.
7
Oroileal transit of slow release 5-aminosalicylic acid.缓释5-氨基水杨酸的口腔至回肠转运
Gut. 1993 May;34(5):669-75. doi: 10.1136/gut.34.5.669.
8
Pharmacokinetics of a 5-aminosalicylic acid enteric-coated tablet in patients with Crohn's disease or ulcerative colitis and in healthy volunteers.5-氨基水杨酸肠溶片在克罗恩病或溃疡性结肠炎患者及健康志愿者体内的药代动力学
Aliment Pharmacol Ther. 1990 Oct;4(5):497-505. doi: 10.1111/j.1365-2036.1990.tb00496.x.
9
Evaluation of an enteric-coated delayed-release 5-aminosalicylic acid tablet in patients with inflammatory bowel disease.炎症性肠病患者中肠溶包衣缓释5-氨基水杨酸片的评估。
Aliment Pharmacol Ther. 1987 Aug;1(4):273-80. doi: 10.1111/j.1365-2036.1987.tb00627.x.
10
Gastrointestinal transit of an enteric-coated delayed-release 5-aminosalicylic acid tablet.
Aliment Pharmacol Ther. 1987 Jun;1(3):209-16. doi: 10.1111/j.1365-2036.1987.tb00620.x.

引用本文的文献

1
Pharmacokinetic considerations in the treatment of inflammatory bowel disease.炎症性肠病治疗中的药代动力学考量
Clin Pharmacokinet. 2001;40(10):723-51. doi: 10.2165/00003088-200140100-00003.
2
Clinical pharmacokinetics of slow release mesalazine.缓释美沙拉嗪的临床药代动力学
Clin Pharmacokinet. 2000 Aug;39(2):85-97. doi: 10.2165/00003088-200039020-00001.
3
Dose loading with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters.缓释美沙拉嗪的负荷剂量:组织药物浓度和标准药代动力学参数的研究
Br J Clin Pharmacol. 2000 Apr;49(4):323-30. doi: 10.1046/j.1365-2125.2000.00164.x.
4
Effects of food on clinical pharmacokinetics.食物对临床药代动力学的影响。
Clin Pharmacokinet. 1999 Sep;37(3):213-55. doi: 10.2165/00003088-199937030-00003.
5
[Pharmacokinetic data for different 5-aminosalicylic acid and budesonide preparations].[不同5-氨基水杨酸和布地奈德制剂的药代动力学数据]
Med Klin (Munich). 1999 Feb 15;94 Suppl 1:16-22. doi: 10.1007/BF03042028.
6
Chronopharmacokinetics. Current status.时辰药代动力学。现状。
Clin Pharmacokinet. 1998 Aug;35(2):83-94. doi: 10.2165/00003088-199835020-00001.
7
[Significance of galenic preparations for luminal release of 5-aminosalicylic acid in human small intestinal lumen].[盖仑制剂对5-氨基水杨酸在人小肠肠腔中腔内释放的意义]
Med Klin (Munich). 1998 May 15;93(5):294-9. doi: 10.1007/BF03044864.

本文引用的文献

1
Simultaneous determination of 5-aminosalicylic acid and 5-acetylaminosalicylic acid by high-performance liquid chromatography.高效液相色谱法同时测定5-氨基水杨酸和5-乙酰氨基水杨酸
J Chromatogr. 1987 Jan 9;385:299-304. doi: 10.1016/s0021-9673(01)94644-8.
2
Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.口服包衣5-氨基水杨酸治疗轻至中度活动性溃疡性结肠炎:一项随机研究。
N Engl J Med. 1987 Dec 24;317(26):1625-9. doi: 10.1056/NEJM198712243172603.
3
Delayed-release mesalazine (5-aminosalicylic acid): coat dissolution and excretion in ileostomy subjects.缓释美沙拉嗪(5-氨基水杨酸):在回肠造口术患者中的包衣溶解及排泄情况
Br J Clin Pharmacol. 1988 Aug;26(2):173-7. doi: 10.1111/j.1365-2125.1988.tb03383.x.
4
Gastrointestinal transit of an enteric-coated delayed-release 5-aminosalicylic acid tablet.
Aliment Pharmacol Ther. 1987 Jun;1(3):209-16. doi: 10.1111/j.1365-2036.1987.tb00620.x.
5
A distribution-free procedure for the statistical analysis of bioequivalence studies.一种用于生物等效性研究统计分析的无分布程序。
Int J Clin Pharmacol Ther Toxicol. 1990 Feb;28(2):72-8.

进餐和昼夜节律对口服肠溶5-氨基水杨酸(5-ASA)吸收的影响。

Prandial and diurnal effects on the absorption of orally administered enteric coated 5-aminosalicylic acid (5-ASA).

作者信息

De Mey C, Meineke I

机构信息

SK&F-Institute of Applied Clinical Pharmacology, Göttingen, Germany.

出版信息

Br J Clin Pharmacol. 1992 Feb;33(2):179-82. doi: 10.1111/j.1365-2125.1992.tb04021.x.

DOI:10.1111/j.1365-2125.1992.tb04021.x
PMID:1550697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1381304/
Abstract

Plasma and urine concentrations of 5-ASA and its N-acetyl metabolite 5-AcASA were measured over 48 h in 12 young healthy male subjects, who received three doses of three times enteric coated 500 mg 5-ASA tablets at 7 h interval, on two occasions 14 days apart. On one occasion the doses were given after standard meals; on the other occasion, they were given 1 h before meals. Administration of the tablets after meals delayed systemic drug absorption but did not affect the extent of absorption. There was a sharp rise in the plasma concentrations of 5-ASA and 5-AcASA in the early morning (i.e. circa 24 h after administration of the 1st dose) independent of when the tablets were taken with respect to the meals. This suggests that tablets or tablet fragments remained in the stomach until the later part of the night. Thus, diurnal effects may be more important than prandial effects in the evaluation of the kinetics of 5-ASA and its metabolites after peroral administration of enteric coated tablets.

摘要

在12名年轻健康男性受试者中,每隔7小时服用三剂500毫克肠溶包衣5 - 氨基水杨酸(5 - ASA)片剂,共服用三次,在间隔14天的两个时间段进行,测定48小时内血浆和尿液中5 - ASA及其N - 乙酰代谢物5 - 乙酰氨基水杨酸(5 - AcASA)的浓度。一次是在标准餐后给药;另一次是在餐前1小时给药。餐后给药延迟了药物的全身吸收,但不影响吸收程度。清晨时(即大约在服用第一剂后24小时),5 - ASA和5 - AcASA的血浆浓度急剧上升,与片剂相对于餐食的服用时间无关。这表明片剂或片剂碎片在胃中一直留存到深夜。因此,在评估口服肠溶包衣片剂后5 - ASA及其代谢物的动力学时,昼夜效应可能比餐时效应更重要。